4.3 Article

The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activation

Related references

Note: Only part of the references are listed.
News Item Dermatology

Structural Studies of Mas-Related G Protein-Coupled Receptors

E. Lerner

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Selective G protein signaling driven by substance P-neurokinin receptor dynamics

Julian A. Harris et al.

Summary: The neuropeptide substance P activates the neurokinin-1 receptor through interactions deep within the receptor, while interactions between the neuropeptide and the receptor extracellular loops regulate G protein signaling selectivity. This study sheds light on how different stimuli can lead to distinct G protein signaling at the same receptor.

NATURE CHEMICAL BIOLOGY (2022)

Article Allergy

MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex

Nithya A. Fernandopulle et al.

Summary: The study found that sugammadex can reduce MRGPRX2 activation induced by NMBAs and other MRGPRX2 agonists, but may be ineffective in controlling acute symptoms. However, sugammadex may have some benefits in reducing MRGPRX2-induced release of CCL2.

CLINICAL AND EXPERIMENTAL ALLERGY (2021)

Review Allergy

Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases

Monica Thapaliya et al.

Summary: Recent research has identified a potential link between atopic dermatitis and allergic asthma with Mas-related G protein-coupled receptor-X2 (MRGPRX2), suggesting that this receptor plays a key role in the pathogenesis of AD and allergic asthma.

CURRENT ALLERGY AND ASTHMA REPORTS (2021)

Article Pharmacology & Pharmacy

The amino-terminal heptapeptide of the algesic substance P provides analgesic effect in relieving chronic neuropathic pain

Julia Nyman et al.

Summary: Acute somatic pain can be effectively managed with opioid agonists, while SP(1-7) and its analog show similar analgesic effects, unlike the algesic effect of SP. In a mouse model of neuropathic pain, SP(1-7) and SP(1-7) amide exhibit dose-dependent anti-allodynia effects, suggesting potential for developing pharmaceuticals for treating neuropathic pain.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Structure, function and pharmacology of human itch receptor complexes

Fan Yang et al.

Summary: MRGPRX2 is a key receptor involved in sensing basic secretagogues and eliciting itch signals and pseudoallergic reactions. The structures of its complex with G(i1) revealed shallow ligand-binding pockets and unique activation processes, providing a structural basis for designing therapies to prevent unwanted pseudoallergic reactions.

NATURE (2021)

Review Allergy

Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease

Saptarshi Roy et al.

Summary: MRGPRX2, activated by various cationic ligands, plays a role in host defense but overactivation may lead to pseudoallergy and various skin diseases. Gain and loss-of-function missense polymorphisms have been identified in MRGPRX2, and the functionality of certain ligands has been defined. The development of small-molecule HDP mimetics that activate MRGPRX2 presents a new therapeutic approach, while MRGPRX2-specific antibodies and inhibitors could be utilized for modulation of allergic and inflammatory diseases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Structure, function and pharmacology of human itch GPCRs

Can Cao et al.

Summary: Structural studies of MRGPRX2 and MRGPRX4 in complex with endogenous and synthetic ligands provide insights for developing therapeutic compounds for pain, itch, and mast cell-mediated hypersensitivity. These receptors are key mediators of itch and related mast cell-mediated hypersensitivity reactions.

NATURE (2021)

Article Biochemistry & Molecular Biology

A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes

Quynh N. Mai et al.

Summary: The study found that the NK1R antagonist Span-Chol has a prolonged analgesic effect mechanism: increasing local concentration at membranes, sustained decrease in NK1R endocytosis, and persistent inhibition of signaling from endosomes.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Neurosciences

A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain

Dustin P. Green et al.

NEURON (2019)

Review Pharmacology & Pharmacy

Understanding Peptide Binding in Class A G Protein-Coupled Receptors

Irina G. Tikhonova et al.

MOLECULAR PHARMACOLOGY (2019)

Article Biochemical Research Methods

Structural analysis of the neuropeptide substance P by using vibrational spectroscopy

Zuzana Jurasekova et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

Simon D. Harding et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Biotechnology & Applied Microbiology

Biological and Pharmacological Aspects of the NK1-Receptor

Susana Garcia-Recio et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Multidisciplinary Sciences

Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions

Benjamin D. McNeil et al.

NATURE (2015)

Article Allergy

Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria

Daisuke Fujisawa et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Letter Dermatology

Substance P Is Upregulated in the Serum of Patients with Chronic Spontaneous Urticaria

Martin Metz et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)

Article Multidisciplinary Sciences

Proteolysis Controls Endogenous Substance P Levels

Andrew J. Mitchell et al.

PLoS One (2013)

Review Biochemistry & Molecular Biology

Relevance of mast cell-nerve interactions in intestinal nociception

Sophie A. van Diest et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)

Review Biochemistry & Molecular Biology

IgE and mast cells in allergic disease

Stephen J. Galli et al.

NATURE MEDICINE (2012)

Article Chemistry, Medicinal

Novel Agonists and Antagonists for Human Protease Activated Receptor 2

Grant D. Barry et al.

JOURNAL OF MEDICINAL CHEMISTRY (2010)

Article Endocrinology & Metabolism

Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality

Rebecca Fransson et al.

NEUROPEPTIDES (2008)

Article Biochemistry & Molecular Biology

Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors

Kazuhiko Tatemoto et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Pharmacology & Pharmacy

Occurrence of substance P(1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level

C Sakurada et al.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2004)

Review Medicine, Research & Experimental

Tachykinins and tachykinin receptors: a growing family

JN Pennefather et al.

LIFE SCIENCES (2004)